Ranking Year:
# | Company Name | Region | Tech Topics | Total |
|---|
1 | Avg patent value: 4.07 M | |||
2 | Avg patent value: 4.02 M | |||
3 | Avg patent value: 2.00 M | |||
4 | Avg patent value: 0 | |||
5 | Avg patent value: 0 |
Top 5 Key Players companies in Hemoperfusion
by Highest Patent Value in the Japan in 2022
The Hemoperfusion top 5 is Discovery PatSnap’ annual ranking of the top 5 Highest Patent Value Hemoperfusion Key Players in the Japan. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2022, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Hemoperfusion or hæmoperfusion (see spelling differences) is a method of filtering the blood extracorporeally (that is, outside the body) to remove a toxin. As with other extracorporeal methods, such as hemodialysis (HD), hemofiltration (HF), and hemodiafiltration (HDF), the blood travels from the patient into a machine, gets filtered, and then travels back into the patient, typically by venovenous access (out of a vein and back into a vein).
Page generation time:
May 01 2025